Kezar Life Sciences, Inc. (KZR)

Trade KZR now with
10/27/2021 8:18:32 AM Kezar Says First Patient Dosed In Phase 1 Trial Of KZR-261 In Advanced Solid Tumor Malignancies
10/5/2021 4:06:43 PM Kezar Life Sciences Appoints Gitanjali Jain As VP, Investor Relations And External Affairs
8/23/2021 7:06:15 AM Kezar Life Sciences Completes Enrollment Of Phase 2 PRESIDIO Trial Of KZR-616 In Polymyositis And Dermatomyositis
11/5/2020 8:50:30 AM Kezar Life Highlights Broad Therapeutic Potential Of KZR-616
10/23/2020 7:05:26 AM Kezar Life Sciences Announces Orphan Drug Designations For KZR-616 For Polymyositis And Dermatomyositis
6/8/2020 10:25:58 PM Kezar Announces Pricing Of Public Offering Of $46.7 Mln Of Common Stock And Pre-Funded Warrants
6/4/2020 11:01:17 AM Stock Alert : Kezar Life Up 89%
1/31/2020 8:16:26 AM Kezar Reports Pricing Of $49.4 Mln Public Offering Of Common Stock And Pre-Funded Warrants
3/12/2019 7:16:29 AM William Blair Reiterates Kezar Life Sciences, Inc. (KZR) At Outperform